Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vancomycin in the Target Site Treatment of Intracranial Infection : a New Strategy for PK/PD Treatment

NCT03585426 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT03585426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03585426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vancomycin in the Target Site Treatment of Intracranial Infection : a New Strategy for PK/PD Treatment
Lead sponsor
Xijing Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2016
Completion date
December 31, 2018
Enrollment
2 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

vancomycin